The Effect of a Stepped-care Metacognition-based Intervention on Managing Fear of Cancer Recurrence

Launched by THE UNIVERSITY OF HONG KONG · Dec 12, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a special program can help cancer survivors manage their fear of cancer coming back. This fear, known as Fear of Cancer Recurrence (FCR), can be quite common among people who have had cancer. The study will involve participants who are Chinese-speaking adults between the ages of 65 and 74 who have finished treatment for curable breast, colorectal, or gynecological cancers within the last five years and have a moderate level of fear about their cancer returning.

If eligible, participants will receive support through a stepped-care approach, which means they will get help tailored to their specific needs. This may include different levels of support based on how they respond to the program. It's important to note that people with advanced cancer or those currently dealing with severe depression or receiving therapy for mental health issues will not be part of this study. Overall, the trial aims to provide effective ways to reduce the anxiety related to cancer recurrence and improve the quality of life for cancer survivors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynecological cancer, who had completed treatment (except endocrine therapy) within five years, and with a Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) score of 13 to 21 indicating subclinical FCR will be included.
• Exclusion Criteria:
• • Patients with metastatic cancer, with a current diagnosis of depression or psychosis, or who are already receiving psychological treatment will be excluded.